Mohammadreza Babaei: Anticoagulation versus No Anticoagulation after Intracranial Hemorrhage in Patients with Atrial Fibrillation
Amir Ghaffari Jolfayi, Research Assistant at Rajaie Cardiovascular, Medical and Research Institute, quoted Mohammadreza Babaei’s post on LinkedIn:
“Excited to share our latest publication in BMC Cardiovascular Disorders!
Title: Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis
Key findings: This meta-analysis of five randomized controlled trials shows that anticoagulation reduces thromboembolic events in patients with atrial fibrillation after intracranial hemorrhage, but is associated with a notably higher risk of recurrent bleeding. It underscores the need for personalized, patient-specific decision-making to balance these risks and benefits.
Special Thanks to Mohammadreza Babaei and the team!
Read the full article here”
Title: Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis
Authors: Mohammadreza Babaei, Parisa Fallahtafti, Sina Rashedi, Amir Ghaffari Jolfayi, Zahra Hosseini, Kaveh Hosseini, Masih Tajdini, Hamidreza Soleimani
Quoting Mohammadreza Babaei’s post:
“Check out our recently published article in BMC Cardiovascular Disorders, titled:
“Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis”
The results of this meta-analysis of five RCTs suggest that anticoagulation provides clinically meaningful reductions in thromboembolic events, but at the cost of a significantly increased risk of bleeding in this population. These findings indicate the importance of carefully selecting patients on an individual basis when weighing the benefits and risks of therapy.
Many thanks to the team members, Parisa Fallahtafti, Sina Rashedi, and Amir Ghaffari Jolfayi for their dedication, and our professors Hamidreza Soleimani, Zahra Hosseini, Kaveh Hosseini, Masih Tajdini for their support and guidance.”
Discover the latest in Hemostasis Today.
-
May 6, 2026, 17:26Joanna Fraser: Highlights from WFH Congress 2026 in Malaysia
-
May 6, 2026, 17:04Nour Al-Mozain: Massive Transfusion in Pediatrics
-
May 6, 2026, 16:36Ney Carter Borges: Randomized Trial of the Vascular Effects of Low-Dose Colchicine in High-Risk Type 2 Diabetes
-
May 6, 2026, 16:35Giuseppe Lippi: Essential Laboratory Testing in Emergencies
-
May 6, 2026, 16:28Anna-Maria Tsilia: Addressing Psychological Aspects of Hemophilia at WFH 2026
-
May 6, 2026, 16:25Manuel A. Lopez Serrano: Mastering Healthcare Through Family, Faith, and Hemophilia
-
May 6, 2026, 16:24Elena Donoso Úbeda: Attending WFH 2026 for Manual Therapy Workshop and Global Collaboration
-
May 6, 2026, 16:22Dhamirah Nazihah Mohd Nasiruddin: Reflecting on a Transformative Fellowship in Haemostasis and Thrombosis at Barts Health
-
May 6, 2026, 16:01Tagreed Alkaltham: What to Expect When You Donate Blood